| Time [days]◆: | |
0
|
28
|
35
|
|---|
|
Treatment group
|
Animal
| | | |
|---|
|
Vaccinated
|
V1
|
0.057*
|
0.185
|
0.736
|
| |
V2
|
0.056
|
0.267
|
0.476
|
| |
V3
|
0.054
| |
0.223
|
| |
V4
|
0.051
|
0.121
|
0.542
|
| |
V5
|
0.052
|
0.054
|
0.408
|
| |
Average#
|
0.054a
|
0.157a
|
0.477
a
|
|
Unvaccinated
|
C1
|
0.055
|
0.059
|
0.099
|
| |
C2
|
0.052
|
0.060
|
0.214
|
| |
C3
|
0.056
|
0.055
|
0.106
|
| |
C4
|
0.057
|
0.060
|
0.067
|
| |
Average
|
0.055a
|
0.059a
|
0.121b
|
- ◆ Calves were infected intranasally with live BRSV 28 days after vaccination with one dose of the inactivated BRSV-PI3-Mh combination vaccine.
- *According to the information of the manufacturer of the assay, values above the cut-off level (0.207) have to be interpreted as positive - indicated by the bold letter type
- # Average values with different superscript letters are significantly different (p < 0.05) from each other.
